ArticleJournal of managed care & specialty pharmacy2020

Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products.

Mindy L Simpson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.